BeOne Medicines Ltd.·4

Jun 12, 5:45 PM ET

Rosenberg Aaron 4

4 · BeOne Medicines Ltd. · Filed Jun 12, 2025

Insider Transaction Report

Form 4
Period: 2025-06-10
Rosenberg Aaron
Chief Financial Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2025-06-10+119,873119,873 total
    Exercise: $20.26Exp: 2035-06-09Ordinary Shares (119,873 underlying)
  • Award

    Ordinary Shares

    2025-06-10+63,674230,802 total
Footnotes (3)
  • [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
  • [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
  • [F3]These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Documents

1 file
  • 4
    wk-form4_1749764747.xmlPrimary

    FORM 4